Last reviewed · How we verify
IVW-1001 Ophthalmic Eyelid Wipe — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
IVW-1001 Ophthalmic Eyelid Wipe (IVW-1001 Ophthalmic Eyelid Wipe) — IVIEW Therapeutics Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| IVW-1001 Ophthalmic Eyelid Wipe TARGET | IVW-1001 Ophthalmic Eyelid Wipe | IVIEW Therapeutics Inc. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- IVW-1001 Ophthalmic Eyelid Wipe CI watch — RSS
- IVW-1001 Ophthalmic Eyelid Wipe CI watch — Atom
- IVW-1001 Ophthalmic Eyelid Wipe CI watch — JSON
- IVW-1001 Ophthalmic Eyelid Wipe alone — RSS
Cite this brief
Drug Landscape (2026). IVW-1001 Ophthalmic Eyelid Wipe — Competitive Intelligence Brief. https://druglandscape.com/ci/ivw-1001-ophthalmic-eyelid-wipe. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab